I N T E R I M R E S U L T S 2 0 0 3
Mar 27, 2015
I N T E R I M R E S U L T S 2 0 0 3
HighlightsHighlights
Good performance in challenging Good performance in challenging marketsmarkets
Continuing strong progress against Continuing strong progress against strategic prioritiesstrategic priorities
Acceleration of growth in second halfAcceleration of growth in second half On track to deliver 2003 targetsOn track to deliver 2003 targets
Financial UpdateFinancial Update
Mark Armour Mark Armour
Chief Financial OfficerChief Financial Officer
Adjusted figures exclude amortisation of goodwill and intangible assets and exceptional items Adjusted figures exclude amortisation of goodwill and intangible assets and exceptional items
TurnoverTurnover
Adjusted operating profitAdjusted operating profit
Operating marginOperating margin
Net interest expenseNet interest expense
Adjusted profit before taxAdjusted profit before tax
%%
%%
%%
% change% changeconstantconstant
20022002 €m €m
20032003€m€m
20022002£m£m
20032003£m£m
2,4672,467
813813505505
20.5%20.5%20.5%20.5%
(172)(172)(107)(107)
641641398398
6 months to 30 June6 months to 30 June
3,9723,9722,3452,345
496496
21.2%21.2%
(88)(88)
408408
3,4243,424
724724
21.2%21.2%
(128)(128)
596596
00
00
+3+3
Adjusted Profit And LossAdjusted Profit And Loss
Reported results reflect currency translation effectsReported results reflect currency translation effects
RevenuesRevenues Operating Operating profitprofit
623
1,003943
646
0
200
400
600
800
1000
1200
20022002 2003200320022002 20032003
202
325 320
219
0
100
200
300
400
20022002 2003200320022002 20032003
Science & MedicalScience & MedicalRevenues up 6% - operating profit up 5% - margin 33.9%Revenues up 6% - operating profit up 5% - margin 33.9%
Underlying revenues up 4%; operating profit up 5%Underlying revenues up 4%; operating profit up 5% Strong subscription renewals and growing online salesStrong subscription renewals and growing online sales Science & Technology revenues up 4%Science & Technology revenues up 4% Health Sciences revenues up 3%Health Sciences revenues up 3% Book publishing programme to accelerate second halfBook publishing programme to accelerate second half
£m£m €€mm £m£m €€mm
LegalLegalRevenues up 4% - operating profit up 17% - margin 20.7%Revenues up 4% - operating profit up 17% - margin 20.7%
Underlying revenues up 2%; operating profit up 13%Underlying revenues up 2%; operating profit up 13% Strong operating margin improvement in first halfStrong operating margin improvement in first half US Legal revenues up 3%; Online up 7% - strong small lawUS Legal revenues up 3%; Online up 7% - strong small law US Corporate & Federal Markets flat; strong risk solutionsUS Corporate & Federal Markets flat; strong risk solutions International underlying revenues up 3%; accelerating demand for onlineInternational underlying revenues up 3%; accelerating demand for online
670
1,079939
643
0
500
1000
1500
122
197
133
194
0
50
100
150
200
250
20022002 2003200320022002 20032003 20022002 2003200320022002 20032003
£m£m £m£m€€€€ €€mm€€mm
RevenuesRevenues Operating Operating profitprofit
EducationEducationRevenues down 5% - operating profit down 32% - margin 7.5%Revenues down 5% - operating profit down 32% - margin 7.5%
Underlying revenues down 6%; operating profit down 35%Underlying revenues down 6%; operating profit down 35% First half growth unrepresentative; revenues and profit second half First half growth unrepresentative; revenues and profit second half
weightedweighted US K-12 revenues flat; orders deferred to second halfUS K-12 revenues flat; orders deferred to second half Testing revenues down 27%; loss of California contractTesting revenues down 27%; loss of California contract International revenues up 1%; UK funding shortfallsInternational revenues up 1%; UK funding shortfalls
449
723
565
387
0
200
400
600
800
48
77
42
29
0
50
100
20022002 2003200320022002 20032003 20022002 2003200320022002 20032003
£m£m £m£m€€mm €€mm
RevenuesRevenues Operating Operating profitprofit
BusinessBusinessRevenues down 6% - operating profit down 12% - margin 17.2%Revenues down 6% - operating profit down 12% - margin 17.2%
Underlying revenues down 6%; operating profit 12%Underlying revenues down 6%; operating profit 12% Rate of decline in advertising markets slowed; few signs of recoveryRate of decline in advertising markets slowed; few signs of recovery Margins defended through continued cost actionsMargins defended through continued cost actions Investment in product quality and disciplined yield managementInvestment in product quality and disciplined yield management Exhibitions resilient: revenues down 3% excluding cyclingExhibitions resilient: revenues down 3% excluding cycling
725
1,167977
669
0
500
1000
1500
2000
133
214
168
115
0
100
200
300
20022002 2003200320022002 20032003 20022002 2003200320022002 20032003
£m£m £m£m€€mm €€mm
RevenuesRevenues Operating Operating profitprofit
Adjusted Profit Before Tax: Adjusted Profit Before Tax: ReconciliationReconciliation
-7%-7%596596+3%+3%4084082003 Adjusted profit before tax2003 Adjusted profit before tax
-10%-10%(64)(64)--(3)(3)Currency translation effectCurrency translation effect
+1%+1%77+1%+1%55Acquisitions/DisposalsAcquisitions/Disposals
+2%+2%1212+2%+2%88Base businessBase business
6416413983982002 Adjusted profit before tax2002 Adjusted profit before tax
% % changechange€€mm
% % changechange£m£m6 months to 30 June6 months to 30 June
Adjusted figures exclude amortisation of goodwill and intangibles and exceptional items Adjusted figures exclude amortisation of goodwill and intangibles and exceptional items
Cash FlowCash Flow
Total cash outflow before financingTotal cash outflow before financing
Free cash flow after dividendsFree cash flow after dividends
Other exceptional itemsOther exceptional items
DisposalsDisposals
Acquisition spendAcquisition spend
% conversion% conversion
2002 2002 €€mm
20032003€€mm
20022002£m£m
20032003£m£m
6 months to 30 June6 months to 30 June
Adjusted operating cash flowAdjusted operating cash flow 177177
36%36%
(5)(5)
(209)(209)
(214)(214)
(97)(97)
8989
(41)(41)
(263)(263)
160160
32%32%
(36)(36)
(190)(190)
(226)(226)
(90)(90)
113113
(37)(37)
(240)(240)
258258
36%36%
(8)(8)
(305)(305)
(313)(313)
(141)(141)
130130
(59)(59)
(383)(383)
258258
32%32%
(58)(58)
(306)(306)
(364)(364)
(145)(145)
182182
(59)(59)
(386)(386)
DividendsDividends
Free cash flow before dividendsFree cash flow before dividends
Reported Profit AttributableReported Profit Attributable
€€0.100.10€€0.090.09Reed Elsevier NV EPSReed Elsevier NV EPS
3.9p3.9p3.9p3.9pReed Elsevier PLC EPSReed Elsevier PLC EPS
15615614214297979797Reported profit attributableReported profit attributable
117117363673732525Exceptional itemsExceptional items
(433)(433)(332)(332)(269)(269)(228)(228)Amortisation of goodwill Amortisation of goodwill and intangible assetsand intangible assets
472472438438293293300300Adjusted profit attributableAdjusted profit attributable
20022002€€mm
20032003€€mm
20022002£m£m
20032003£m£m6 months to 30 June6 months to 30 June
Adjusted Earnings and DividendsAdjusted Earnings and Dividends
-11% -11%
€€0.080.08+3%+3%3.33.3ppEqualised dividendsEqualised dividends
+3%+3%-7%-7%€€0.280.28+2%+2%12.6p12.6pAdjusted EPSAdjusted EPS
% change % change constantconstant
Reed Reed ElsevierElsevier
NVNV
ReedReed Elsevier Elsevier
PLCPLC
Strategy & ExecutionStrategy & Execution
Crispin Davis Crispin Davis
Chief Executive OfficerChief Executive Officer
Reed Elsevier:Reed Elsevier:Key Objectives For 2003Key Objectives For 2003
Maximise above market organic Maximise above market organic growth from four core businessesgrowth from four core businesses
Execute and deliver on all strategic Execute and deliver on all strategic milestonesmilestones
Improve operating margin further Improve operating margin further through increased efficiencythrough increased efficiency
Deliver double digit earnings growthDeliver double digit earnings growth
ON TRACK
ON TRACK
ON TRACK
ON TRACK
Science & Medical:Science & Medical:ScienceDirect:ScienceDirect: Increasing UsageIncreasing Usage
Article downloads (millions)Article downloads (millions)
1616
19991999
2828
20002000
5050
20012001
8686
20022002 2003*2003*
124124
* 12 months to 30 June* 12 months to 30 June
Science & Medical:Science & Medical:ScienceDirect:ScienceDirect: Expanding ContentExpanding Content
Full text articles (millions)Full text articles (millions)
1.21.2
20002000
1.81.8
20012001
3.33.3
20022002 2003*2003*
4.54.5
* At 30 June* At 30 June
Science & Technology:Science & Technology:Continued Low Attrition
* Full Year Estimate* Full Year Estimate
5.2%5.2%
4.0%4.0%4.0%4.0%
8.5%8.5%
2003*2003* 20012001 2000200019991999 20022002
4.0%4.0%
Science & Medical: Science & Medical: Health SciencesHealth Sciences
Successful front list publishing programmeSuccessful front list publishing programme Accelerating electronic information businessAccelerating electronic information business
– MD Consult 13% aheadMD Consult 13% ahead– Wide ranging introduction of new productsWide ranging introduction of new products– Significant online education training Significant online education training
opportunitiesopportunities
Accelerating international expansionAccelerating international expansion– Local versioning of authoritative contentLocal versioning of authoritative content– Acquisition of Holtzbrinck STM in GermanyAcquisition of Holtzbrinck STM in Germany
Integration of book production and Integration of book production and distribution on trackdistribution on track
Science & Medical: Science & Medical: 20032003 OutlookOutlook
Revenue growth to accelerateRevenue growth to accelerate– Strong 2003 book publishing programmeStrong 2003 book publishing programme– Continued growth in electronic salesContinued growth in electronic sales
Cost efficiencies and operational Cost efficiencies and operational gearing to drive further margin gearing to drive further margin improvementimprovement
Expansion of content and innovative Expansion of content and innovative electronic serviceselectronic services
Legal:Legal:US Legal Online Usage GrowingUS Legal Online Usage Growing
Growth in commercial Growth in commercial searchessearches
+22%+22%
+17%+17%
+31%+31%
Online revenues up 7%Online revenues up 7%
19991999 200220022001200120002000 2003*2003*
+20%+20%
* To 30 June* To 30 June
Legal: Legal: Risk Solutions: Long Term GrowthRisk Solutions: Long Term Growth
1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003E1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003E
Enterprise/Lib.
Total LN
Risk Mgmt.
Legal/Tax
Law Firms
CFM
Growth in public recordsGrowth in public records
Legal:Legal:Optimising Cost EfficiencyOptimising Cost Efficiency
Operating marginOperating margin
24.9%24.9%
19991999
20.1%20.1%
20012001
19.7%19.7%
20002000 2003*2003*
c.22.5%c.22.5%
*Full Year Estimate*Full Year Estimate
20022002
21.3%21.3%
Legal: Legal: 2003 Outlook2003 Outlook
Maintain above market revenue Maintain above market revenue momentum in US marketsmomentum in US markets
Acceleration of growth from new product Acceleration of growth from new product initiatives and acquired businessesinitiatives and acquired businesses
Margin improvement from focused cost Margin improvement from focused cost actions, releasing funds for investmentactions, releasing funds for investment
International – strong growth in online International – strong growth in online sales mitigated by print migration and sales mitigated by print migration and weak corporate marketsweak corporate markets
Education:Education:US Schools MarketUS Schools Market
Attractive long term growth marketAttractive long term growth market Strong federal and state commitmentStrong federal and state commitment Short term market weakness in Short term market weakness in
2003/20042003/2004– Low point in adoption cycleLow point in adoption cycle– State budget pressuresState budget pressures
2003 impact from federal funding 2003 impact from federal funding modestmodest
Education:Education:Winning Performance in 2003 Winning Performance in 2003 Adoption RevenuesAdoption Revenues
# 1# 1# 1# 1ScienceScience
# 4# 4# 1# 1Social StudiesSocial Studies
# 3# 3# 1# 1MathematicsMathematics
# 1# 1# 1# 1Language ArtsLanguage Arts
# 1# 1# 3# 3Reading/LiteratureReading/Literature
SecondarySecondaryElementaryElementary
Overall Overall # 1# 1
Overall Overall # 1 # 1 ==
Based on estimated share of total available adoption revenuesBased on estimated share of total available adoption revenues
Education:Education:Harcourt AssessmentHarcourt Assessment
2003 revenues impacted by loss of 2003 revenues impacted by loss of CaliforniaCalifornia
Momentum regenerated: management, Momentum regenerated: management, product, scoring, operationsproduct, scoring, operations
New edition of Stanford Achievement New edition of Stanford Achievement Test launchedTest launched
Awarded 7 out of 11 state contracts Awarded 7 out of 11 state contracts tenderedtendered
Strong pipeline of state level bidsStrong pipeline of state level bids
Education: Education: 2003 Outlook2003 Outlook
US schools market broadly flat; small US schools market broadly flat; small decline possibledecline possible
Success in state adoptions will come Success in state adoptions will come through as second half salesthrough as second half sales
Continued success in state Testing Continued success in state Testing contractscontracts
Margin improvement through continuing Margin improvement through continuing process efficiency process efficiency
Business: Business: Trading environmentTrading environment
No marked deterioration; no real sign of No marked deterioration; no real sign of recoveryrecovery
OverallOverallOverallOverall
Variability by sector: Growth in Entertainment; Variability by sector: Growth in Entertainment; Manufacturing and Electronics still weak; Manufacturing and Electronics still weak; Construction late cycle Construction late cycle
USUSUSUS
Economic conditions weaker; resilient Economic conditions weaker; resilient subscription revenues mitigated advertising subscription revenues mitigated advertising declines across all sectorsdeclines across all sectors
Continental Continental EuropeEuropeContinental Continental EuropeEurope
UKUKUKUK Variability by sector; Aerospace, Social Variability by sector; Aerospace, Social Services and Property holding upServices and Property holding up
Impact of economic weakness, SARS and Iraq; Impact of economic weakness, SARS and Iraq; cycling out of non-annual showscycling out of non-annual shows
Global Global ExhibitionsExhibitionsGlobal Global ExhibitionsExhibitions
Business:Business:Online Revenue GrowthOnline Revenue Growth
$57m$57m
$95m$95m
$115m$115m
$22m$22m
20022002200120012000200019991999 2003*2003*
$140m$140m
* Full year estimate* Full year estimate
Business: Business: Market OutperformanceMarket Outperformance
Continuing to build market share on magazines
Further improvement in yield management
Tight control of costs Exhibitions challenging, but showing
resilience
Business: Business: 2003 Outlook2003 Outlook
Continued tough trading conditions across markets
Product quality, sales effectiveness and yield management restrict revenue decline
Continued margin improvement, mitigating impact on profitability
Significant upside as economy recovers
State annotated State annotated codescodes
e-Filing, e-Access, e-Filing, e-Access, e-Discoverye-Discovery
Integrated Risk Integrated Risk SolutionsSolutionscapabilitycapability
Industry DossierIndustry Dossier Global Legal Global Legal
PlatformPlatform
Reference Reference works onlineworks online
Scirus search Scirus search engineengine
MD Consult MD Consult upgradeupgrade
EVOLVE EVOLVE medical medical education education platformplatform
ScienceDirect ScienceDirect multimedia multimedia capabilitycapability
Market Market leading leading adoption adoption programmesprogrammes
Online HRW Online HRW BasalBasal
Stanford 10Stanford 10 Texas Texas
STARgateSTARgate Alzheimer Alzheimer
QuicktestQuicktest
Totaljobs.comTotaljobs.com KellySearchKellySearch 14 magazines 14 magazines
relaunchedrelaunched RCD ConnectRCD Connect 16 new exhibitions 16 new exhibitions
launchedlaunched
Product Upgrade Initiatives: Product Upgrade Initiatives:
Elsevier Elsevier Dedicated Engineering/Dedicated Engineering/Life Sciences/Chemistry Life Sciences/Chemistry
sales forcessales forces
Reed BusinessReed BusinessCustomer researchCustomer researchprogramme for all programme for all
magazinesmagazines
LexisNexisLexisNexisStrengthened smallStrengthened small
law programmelaw programme
All DivisionsAll DivisionsExecution ofExecution of
sales audit programmessales audit programmes
ElsevierElsevierCoordinatedCoordinated
global price increaseglobal price increaseprogrammeprogramme
Elsevier/Elsevier/LexisNexisLexisNexisImplementation ofImplementation of
global branding programmeglobal branding programme
HarcourtHarcourt Major upgrade ofMajor upgrade of
Open Territories salesOpen Territories salesforceforce
HarcourtHarcourtGlobal LibraryGlobal Library
marketing programmemarketing programme
Reed BusinessReed BusinessRCD nationalRCD national
accounts programmeaccounts programme
Reed BusinessReed BusinessSuccessful yieldSuccessful yield
management management programmeprogramme
LexisNexisLexisNexisKey accountKey accountrelationship relationship programmeprogramme
ElsevierElsevierIntroduction ofIntroduction of
Health Sciences Health Sciences telesalestelesales
Sales and Marketing Initiatives: Sales and Marketing Initiatives:
Infrastructure and Cost Initiatives:Infrastructure and Cost Initiatives:
New content management systemsNew content management systems New customer fulfilment systemsNew customer fulfilment systems New editorial systemsNew editorial systems Off-shore printing/outsourcingOff-shore printing/outsourcing Pre-plate restructuringPre-plate restructuring Electronic author workbenchElectronic author workbench New CRM systemsNew CRM systems
2000-2002: $500m of savings achieved 2000-2002: $500m of savings achieved 2003: $150m further savings2003: $150m further savings
Risk Risk ManagementManagement
e-Discovery, e-e-Discovery, e-Filing, e-AccessFiling, e-Access
Endeavor Endeavor Library Library ServicesServices
International International Healthcare Healthcare
e-Healthcaree-Healthcare
Clinical Clinical TestingTesting
Customised Customised State State TestingTesting
On-line On-line recruitment, recruitment, directoriesdirectories
Variety Variety franchisefranchise
““Shooting Stars”Shooting Stars”
All businesses outperforming in dynamic growth sectorsAll businesses outperforming in dynamic growth sectors Annual revenue growth at high single/double digitAnnual revenue growth at high single/double digit Total revenue c.$700mTotal revenue c.$700m
Reed Elsevier:Reed Elsevier:Key Objectives For 2003 UnchangedKey Objectives For 2003 Unchanged
Maximise above market organic growth Maximise above market organic growth from four core businessesfrom four core businesses
Execute and deliver on all strategic Execute and deliver on all strategic milestonesmilestones
Improve operating margin further Improve operating margin further through increased efficiencythrough increased efficiency
Deliver double digit earnings growthDeliver double digit earnings growth
ON TRACK
ON TRACK
ON TRACK
ON TRACK
I N T E R I M R E S U L T S 2 0 0 3
AppendicesAppendices
Turnover: ReconciliationTurnover: Reconciliation
%%changechange€€mm
% % changechange£m£m
-14%-14%3,4243,424-5%-5%2,3452,3452003 Turnover2003 Turnover
-14%-14%(541)(541)-5%-5%(117)(117)Currency translation effectCurrency translation effect
--(19)(19)--(13)(13)DisposalsDisposals
+1%+1%5454+1%+1%3737AcquisitionsAcquisitions
-1%-1%(42)(42)-1%-1%(29)(29)Base businessesBase businesses
3,9723,9722,4672,4672002 Turnover2002 Turnover
6 months to 30 June6 months to 30 June
First half average rates:First half average rates:
20032003 20022002
$:£$:£ 1.611.61 1.441.44
$:€ $:€ 1.10 1.10 0.900.90
€€:£ 1.46 1.61:£ 1.46 1.61
Full year average rates:Full year average rates:
2003*2003* 2002 2002
$:£$:£ 1.62 1.62 1.501.50
$:€ $:€ 1.13 1.13 0.940.94
€€:£ 1.43 1.59:£ 1.43 1.59
Currency Profile:Currency Profile:Adjusted Profit Before TaxAdjusted Profit Before Tax
LTM to 30 June 2003LTM to 30 June 2003LTM to 30 June 2003LTM to 30 June 2003
EuroEuro41%41%
SterlingSterling21%21%
US DollarUS Dollar33%33%
OtherOther5%5%
*2003 average rates (approx) if recent spot *2003 average rates (approx) if recent spot rates continue ($1.62:£1; $1.15:€1; €1.41:£1)rates continue ($1.62:£1; $1.15:€1; €1.41:£1)
20032003 20022002 20032003 20022002£m£m £m£m €€mm €€mm
Adjusted operating cash flowAdjusted operating cash flow 177 177 160160 258258 258258
InterestInterest (85) (85) (108)(108) (124)(124) (174)(174)
TaxTax (97)(97) (88)(88) (142)(142) (142)(142)
DividendsDividends (209)(209) (190)(190) (305)(305) (306)(306)
Free cash outflowFree cash outflow (214)(214) (226)(226) (313)(313) (364)(364)
6 months to 30 June6 months to 30 June
Free Cash FlowFree Cash Flow
Cash Flow SeasonalityCash Flow Seasonality
Cash flow Cash flow conversion %conversion %
90%90% 36%36% 136%136%
1,0271,027 177177 850850
£m£m
12 months12 monthsto 30 Juneto 30 June
£m£m £m£m2003 20022003 200220032003
90%90% 36%36% 136%136%
1,4991,499 258258 1,2411,241
€€mm
12 months12 monthsto 30 Juneto 30 June
€€mm €€mm2003 20022003 200220032003
H1 H2H1 H2 H1 H2 H1 H2
Adjusted operating Adjusted operating cash flowcash flow
Exceptional ItemsExceptional Items
153153(12)(12)9595(9)(9)Net tax (charge)/creditNet tax (charge)/credit
(36)(36)4848(22)(22)3434Exceptional credit/(charge) Exceptional credit/(charge) before taxbefore tax
14148282995757Net profit on sale of fixed asset Net profit on sale of fixed asset investments and businessesinvestments and businesses
(50)(50)(34)(34)(31)(31)(23)(23)Charged to operating profitCharged to operating profit
(36)(36)(22)(22)(22)(22)(15)(15)Acquisition related costsAcquisition related costs
(14)(14)(12)(12)(9)(9)(8)(8)Reorganisation costsReorganisation costs
20022002€€mm
20032003€€mm
20022002£m£m
20032003£m£m6 months to 30 June6 months to 30 June
11711736 36 737325 25 Total exceptional creditTotal exceptional credit
Balance SheetBalance Sheet
1,0301,0301,0001,000669669694694
Net debtNet debt 5,0765,0764,2094,2093,2963,2962,9232,923
Other net liabilities/minoritiesOther net liabilities/minorities
4,4034,4033,7673,7672,8592,8592,6162,616Shareholders’ fundsShareholders’ funds
10,50910,5098,9768,9766,8246,8246,2336,233
248248206206161161143143InvestmentsInvestments
764764704704496496489489Tangible fixed assetsTangible fixed assets
9,5639,5637,9797,9796,2106,2105,5415,541Goodwill/intangible assetsGoodwill/intangible assets
20022002€€mm
20032003€€mm
20022002£m£m
20032003£m£m
(66)(66)8787(43)(43)6060Working capitalWorking capital
10,50910,5098,9768,9766,8246,8246,2336,233
At 30 June At 30 June
Dividend EqualisationDividend Equalisation
Reed Elsevier PLC (p)Reed Elsevier PLC (p)
20032003 20022002 %%ChangeChange
InterimInterim
3.33.3 3.23.2
UK tax credit rateUK tax credit rate
Gross (p)Gross (p)
Equalisation ratioEqualisation ratio
Exchange rate (€:£)Exchange rate (€:£)
Reed Elsevier NV (€)Reed Elsevier NV (€)
10%10% 10%10%
3.673.67 3.563.56
1.5381.538
1.411.41
0.080.08
1.5381.538
1.591.59
0.090.09 -11%-11%
+3%+3%
This presentation contains forward-looking statements within the meaning of Section 27A ofthe US Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of1934, as amended. These statements concern future matters, such as the features andfunctions of, and markets for, products and services offered by Reed Elsevier, and ReedElsevier’s business plans and strategies. Forward-looking statements are based on the currentexpectations of the management of Reed Elsevier and are subject to risks and uncertainties.Actual results and events could differ materially from the results discussed in the forward-looking statements. Factors which could cause or contribute to differences in results include,but are not limited to, general economic conditions and business conditions in Reed Elsevier’smarkets, customers’ acceptance of its products and services, the actions of competitors,changes in law and legal interpretation affecting Reed Elsevier’s intellectual property rights,and the impact of technological change. Reed Elsevier is not under any obligation (andexpressly disclaims any such obligation) to update or alter its forward-looking statementswhether as a result of new information, future events or otherwise.
This presentation contains forward-looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. These statements concern future matters, such as the features and functions of, and markets for, products and services offered by Reed Elsevier, and Reed Elsevier’s business plans and strategies. Forward-looking statements are based on the current expectations of the management of Reed Elsevier and are subject to risks and uncertainties. Actual results and events could differ materially from the results discussed in the forward-looking statements. Factors which could cause or contribute to differences in results include, price and currency fluctuations; the impact of electronic or other distribution formats; legislative, fiscal and regulatory developments and political risks, general conditions in the businesses, actions of competitors and general economic conditions. Reed Elsevier is not under any obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.
I N T E R I M R E S U L T S 2 0 0 3